Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Quest Diagnostics (NYSE: DGX) will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026 at 4:30 p.m. PT. Jim Davis, Chairman, CEO and President, and Sam Samad, EVP and CFO, will discuss the company’s strategy, performance, and market trends during a presentation and Q&A.
The session will be webcast live and available at ir.QuestDiagnostics.com; an archived webcast will be posted within 24 hours and will remain available through February 11, 2026.
Details
News Market Reaction – DGX
On Dec 19, the day this news came out, DGX closed 0.05% below the previous close.
Data tracked by StockTitan Argus for the Dec 19 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 12, 2026
- Company presentation at 4:30 p.m. Pacific Time
- Webcast availability
- Until February 11, 2026
- Archived conference webcast access window
AI-generated analysis. How Rhea-AI works. Not financial advice.
The presentation and Q&A session will be webcast live during the conference and will be available at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 11, 2026.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-44th-annual-jp-morgan-healthcare-conference-302647252.html
SOURCE Quest Diagnostics
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.